Epstein–Barr Virus BRRF1 Induces Butyrophilin 2A1 in Nasopharyngeal Carcinoma NPC43 Cells via the IL-22/JAK3-STAT3 Pathway
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252413452 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yue Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, Fuyang Normal University, Fuyang 236000, China. Hauptthemen laut MEDLINE: STAT3 Transcription Factor, Nasopharyngeal Carcinoma, Butyrophilins, Interleukins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Health and Medical Research Fund, Research Grant Council - Theme-based Research Scheme, Research Grant Council - General Research Fund.
Abstract (Originalsprache)
Epstein–Barr virus is highly associated with nasopharyngeal carcinoma (NPC) with genes expressed for tumor transformation or maintenance of viral latency, but there are certain genes that can modulate immune molecules. Butyrophilin 2A1 (BTN2A1) is an important activating protein for presenting phosphoantigens for recognition by Vγ9Vδ2 T cells to achieve antitumor activities. We have previously shown that Vγ9Vδ2 T cells achieve efficacy against NPC when BTN2A1 and BTN3A1 are upregulated by stimulating EBV gene expression, particularly LMP1. While BTN3A1 can be induced by the LMP1-mediated IFN-γ/JNK/NLRC5 pathway, the viral gene that can regulate BTN2A1 remains elusive. We showed that BTN2A1 expression is directly mediated by EBV BRRF1, which can trigger the BTN2A1 promoter and downstream JAK3-STAT3 pathway in NPC43 cells, as shown by RNA-seq data and verified via inhibitor experiments. Furthermore, BRRF1 downregulated IL-22 binding protein (IL-22RA2) to complement the EBNA1-targeting probe (P4)-induced IL-22 expression. Therefore, this study elucidated a new mechanism of stimulating BTN2A1 expression in NPC cells via the EBV gene BRRF1. The JAK3-STAT3 pathway could act in concordance with IL-22 to enhance the expression of BTN2A1, which likely leads to increased tumor cell killing by Vγ9Vδ2 T cells for enhanced potential as immunotherapy against the cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical School, Fuyang Normal University, Fuyang 236000, China.
- Department of Biology, Faculty of Science, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China.
- Department of Chemistry, Faculty of Science, Hong Kong Baptist University, Kowloon Tong, Hong Kong SAR, China.
ORCID-Profile: Ka Sin Lui, Allen Ka Loon Cheung
Förderung
- Health and Medical Research Fund
- Research Grant Council - Theme-based Research Scheme
- Research Grant Council - General Research Fund
- Pneumoconiosis Compensation Fund Board Research Grant
- Research Grant Council (RGC) Theme-based Research Scheme
- General Research Fund
- Interdisciplinary Research Matching Scheme
- Faculty Research Grant
Zitieren
APA
Liu, Y., Lui, K. S., Ye, Z., Chen, L., & Cheung, A. K. L. (2024). Epstein–Barr Virus BRRF1 Induces Butyrophilin 2A1 in Nasopharyngeal Carcinoma NPC43 Cells via the IL-22/JAK3-STAT3 Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413452
Vancouver
Liu Y, Lui KS, Ye Z, Chen L, Cheung AKL. Epstein–Barr Virus BRRF1 Induces Butyrophilin 2A1 in Nasopharyngeal Carcinoma NPC43 Cells via the IL-22/JAK3-STAT3 Pathway. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413452
BibTeX
@article{Liu2024,
author = {Liu, Yue and Lui, Ka Sin and Ye, Zuodong and Chen, Luo and Cheung, Allen Ka Loon},
title = {Epstein–Barr Virus BRRF1 Induces Butyrophilin 2A1 in Nasopharyngeal Carcinoma NPC43 Cells via the IL-22/JAK3-STAT3 Pathway},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252413452}
}
EUVIMED